A Study of PEP08 in Patients With MTAP-Del Advanced or Metastatic Solid Tumors - Join Clinical Trial NCTNCT06973863
How to Join This Clinical Trial - NCTNCT06973863
Learn how to participate in this PHASE1 trial studying an investigational therapy for Advanced Solid Tumor, Solid Tumors, MTAP-deleted Solid Tumors, MTAP Deletion. Current status: NOT_YET_RECRUITING.
Am I Eligible for This Clinical Trial?
This clinical research study is looking for participants with Advanced Solid Tumor, Solid Tumors, MTAP-deleted Solid Tumors, MTAP Deletion. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.
- Condition Being Studied
- Advanced Solid Tumor, Solid Tumors, MTAP-deleted Solid Tumors, MTAP Deletion
- Treatment Being Tested
- Investigational treatment
- Study Phase
- PHASE1 - Early safety study
- Enrollment Status
- NOT_YET_RECRUITING
- Study Identifier
- NCTNCT06973863 - ClinicalTrials.gov Identifier
- Sponsored By
- Study sponsor
What to Expect as a Participant
Participating in this clinical trial involves:
- Initial screening to determine eligibility
- Regular study visits and health assessments
- Receiving the study treatment or placebo
- Medical monitoring and follow-up care
- Contributing to medical research that may help others
- Potential access to new treatments before they're widely available
Clinical Trial Benefits and Compensation
Participants in this clinical research study may receive:
- Close medical monitoring by healthcare professionals
- Access to potential new treatments
- Compensation for time and travel (varies by study)
- No-cost study-related medical care
- The opportunity to help advance medical knowledge
Where Is This Clinical Trial Located?
This study is enrolling participants at 1 locations. Find a study site near you:
Clinical Research Site
Wentworthville, New South Wales 2145 - Australia
Status: Contact for availability
How to Enroll in This Study
To learn more about participating in this PHASE1 clinical trial for Advanced Solid Tumor, Solid Tumors, MTAP-deleted Solid Tumors, MTAP Deletion:
- Review the eligibility criteria with your healthcare provider
- Contact the study team for a pre-screening interview
- Schedule an in-person screening visit if eligible
- Review and sign the informed consent form
- Begin participation in the clinical trial
Why Choose Quri.ai Study Finder
Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:
- Discover clinical trials before competitors
- Access exclusive contact information
- Track sponsor pipelines and opportunities
- Connect with decision makers directly
- Win more business partnerships